Cumberland Pharmaceuticals increases ATM offering size to $10M

CUMBERLAND PHARMACEUTICALS INC

Maximum aggregate offering price under Sales Agreement with H.C. Wainwright raised to $10,000,000.
Prospectus supplement filed February 14, 2025, amending prior $0 limit or undisclosed prior cap.
Shares of common stock (CPIX) may be sold at-the-market from time to time.
No specific use of proceeds stated in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.